Document is current

Any future updates will be listed below

957 The ATR-inhibitor ceralasertib modulates the tumor microenvironment and improves the effect of anti-PDL1 by activating type I IFN pathway

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.0957

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark